Harold Andre Aubrey de Lavenu - 31 Dec 2018 Form 5 Insider Report for CEN BIOTECH INC

Role
Director
Signature
/s/ Harold Aubrey de Lavenu
Issuer symbol
N/A
Transactions as of
31 Dec 2018
Net transactions value
-$274,611
Form type
5
Filing time
28 May 2021, 08:32:05 UTC
Previous filing
28 May 2021
Next filing
04 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CENBF Convertible note Other $274,611 -171,632 -24% $1.60* 548,980 15 Nov 2018 Common Stock 107,270 $1.60 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 15, 2018, $171,632 of a $200,000 convertible promissory note issued by the issuer on November 25, 2016 to the reporting person was repaid by the issuer to the reporting person thereby reducing the amount due under the note to $28,368 and accordingly reducing the number of common stock shares of the issuer issuable upon conversion of the promissory note from 125,000 shares of common stock by 107,270 shares of common stock to 17,730 shares of common stock.
F2 The convertible note matured on November 25, 2018, however, the ability to convert the note into shares did not expire on such maturity date.
F3 At December 31, 2018, the reporting person also held 33,321 shares of the issuer's common stock directly, and held convertible promissory notes convertible into 548,980 shares of the issuer's common stock.

Remarks:

The reporting person has served as a member of the board of directors of the issuer since July 2017 and was appointed to serve as a vice president of the issuer on April 2, 2021.